Do Gut Hormones Contribute to Weight Loss and Glycaemic Outcomes after Bariatric Surgery?
Open accessThe DOI matches its Crossref record; 182 of the 183 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Bariatric surgery is an effective intervention for management of obesity through treating dysregulated appetite and achieving long-term weight loss maintenance. Moreover, significant changes in glucose homeostasis are observed after bariatric surgery including, in some cases, type 2 diabetes remission from the early postoperative period and postprandial hypoglycaemia. Levels of a number of gut hormones are dramatically increased from the early period after Roux-en-Y gastric bypass and sleeve gastrectomy—the two most commonly performed bariatric procedures—and they have been suggested as important mediators of the observed changes in eating behaviour and glucose homeostasis postoperatively. In this review, we summarise the current evidence from human studies on the alterations of gut hormones after bariatric surgery and their impact on clinical outcomes postoperatively. Studies which assess the role of gut hormones after bariatric surgery on food intake, hunger, satiety and glucose homeostasis through octreotide use (a non-specific inhibitor of gut hormone secretion) as well as with exendin 9–39 (a specific glucagon-like peptide-1 receptor antagonist) are reviewed. The potential use of gut hormones as biomarkers of successful outcomes of bariatric surgery is also evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“thus potentially enabling a larger effect of exogenously given GLP1-RA [34].”
From Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study (2023) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The notion for combining entero-pancreatic hormone-based therapies for obesity treatment is supported by the efficacy of bariatric surgery on WL, an intervention leading to increased postprandial levels of multiple entero-pancreatic hormones [31, 32].”
From What is the pipeline for future medications for obesity? (2025) · cites this paper as [32]
In the citing paper
“The rapid delivery of nutrients to the L-cells in the distal small intestine and colon after bariatric surgery leads to increased secretion of gut hormones, especially postprandial GLP-1 and peptide YY.”
In the citing paper
“Both hormones are known to reduce food intake by stimulating satiety and decreasing appetite, which most likely plays a central role for the weight loss effect of bariatric surgery [34].”
In the citing paper
“the study by Lautenbach includes “poor” responders to bariatric surgery, which have been shown to have lower endogenous GLP-1 levels”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haslam, D. W., & James, W. P. T. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67483-1 · Cited by 3,757
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass Surgery
Cummings, D. E., Weigle, D. S., Frayo, R. S., Breen, P. A., Ma, M. K., Dellinger, E. P., & Purnell, J. Q. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012908 · Cited by 2,241
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Glucagon-like peptide-1 7–36: a physiological incretin in man
Kreymann, B., Ghatei, M. A., Williams, G., & Bloom, S. R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91194-9 · Cited by 1,928
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Bray, G. A., Kim, K. K., Wilding, J. P. H., & on behalf of the World Obesity Federation (2017) · Obesity Reviews · doi:10.1111/obr.12551 · Cited by 1,612
Inhibition of Food Intake in Obese Subjects by Peptide YY 3–36
Batterham, R. L., Cohen, M. A., Ellis, S. M., Le Roux, C. W., Withers, D. J., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030204 · Cited by 1,604
Long-term persistence of hormonal adaptations to weight loss
Sumithran, P., Prendergast, L. A., Delbridge, E., Purcell, K., Shulkes, A., Kriketos, A., & Proietto, J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105816 · Cited by 1,449 · cited 3×
“On a low-calorie diet, people usually report an increase in hunger, a decrease in satiety and an increased desire to eat [18,27,28] and this is likely due to robust compensatory processes that resist a drift of body fat stores below an established “set point” [29,30].”
BackgroundBray, G. A., Frühbeck, G., Ryan, D. H., & Wilding, J. P. H. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00271-3 · Cited by 1,036
Müller, T. D., Nogueiras, R., Andermann, M. L., Andrews, Z. B., Anker, S. D., Argente, J., Batterham, R. L., Benoit, S. C., Bowers, C. Y., Broglio, F., et al. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.03.005 · Cited by 1,034
IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures
Angrisani, L., Santonicola, A., Iovino, P., Vitiello, A., Higa, K., Himpens, J., Buchwald, H., & Scopinaro, N. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3450-2 · Cited by 1,032
Roux, C. W. L., Aylwin, S. J. B., Batterham, R. L., Borg, C. M., Coyle, F., Prasad, V., Shurey, S., Ghatei, M. A., Patel, A. G., & Bloom, S. R. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000183349.16877.84 · Cited by 985
Khera, R., Murad, M. H., Chandar, A. K., Dulai, P. S., Wang, Z., Prokop, L. J., Loomba, R., Camilleri, M., & Singh, S. (2016) · JAMA · doi:10.1001/jama.2016.7602 · Cited by 865
on behalf of the NN8022-1923 Investigators, Wadden, T. A., Hollander, P., Klein, S., Niswender, K., Woo, V, Hale, P. M., & Aronne, L. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.120 · Cited by 842
Welbourn, R., Hollyman, M., Kinsman, R., Dixon, J., Liem, R., Ottosson, J., Ramos, A., Våge, V., Al-Sabah, S., Brown, W., et al. (2019) · Obesity Surgery · doi:10.1007/s11695-018-3593-1 · Cited by 824
O'Neil, P. M., Birkenfeld, A. L., McGowan, B., Mosenzon, O., Pedersen, S. D., Wharton, S., Carson, C. G., Jepsen, C. H., Kabisch, M., & Wilding, J. P. H. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31773-2 · Cited by 814
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass
le Roux, C. W., Welbourn, R., Werling, M., Osborne, A., Kokkinos, A., Laurenius, A., Lönroth, H., Fändriks, L., Ghatei, M. A., Bloom, S. R., et al. (2007) · Annals of Surgery · doi:10.1097/sla.0b013e3180caa3e3 · Cited by 741 · cited 4×
“In contrast, patients who had undergone AGB (an operation with minimal effect on gut hormones), did not exhibit changes in appetite or food intake with octreotide administration [19].”
BackgroundMethodResultInfluentialLaferrère, B., Teixeira, J., McGinty, J., Tran, H., Egger, J. R., Colarusso, A., Kovack, B., Bawa, B., Koshy, N., Lee, H., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2851 · Cited by 682
Function and mechanisms of enteroendocrine cells and gut hormones in metabolism
Gribble, F. M., & Reimann, F. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0168-8 · Cited by 670
Patti, M., Houten, S. M., Bianco, A. C., Bernier, R., Larsen, P. R., Holst, J. J., Badman, M. K., Maratos‐Flier, E., Mun, E. C., Pihlajamaki, J., et al. (2009) · Obesity · doi:10.1038/oby.2009.102 · Cited by 591
Sleeve Gastrectomy and Gastric Banding: Effects on Plasma Ghrelin Levels
Langer, F. B., Reza Hoda, M. A., Bohdjalian, A., Felberbauer, F. X., Zacherl, J., Wenzl, E., Schindler, K., Luger, A., Ludvik, B., & Prager, G. (2005) · Obesity Surgery · doi:10.1381/0960892054621125 · Cited by 566
Peterli, R., Wölnerhanssen, B., Peters, T., Devaux, N., Kern, B., Christoffel-Courtin, C., Drewe, J., von Flüe, M., & Beglinger, C. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181ae32e3 · Cited by 565
Welbourn, R., Pournaras, D. J., Dixon, J., Higa, K., Kinsman, R., Ottosson, J., Ramos, A., van Wagensveld, B., Walton, P., Weiner, R., et al. (2018) · Obesity Surgery · doi:10.1007/s11695-017-2845-9 · Cited by 555
Attenuated Peptide YY Release in Obese Subjects Is Associated with Reduced Satiety
le Roux, C. W., Batterham, R. L., Aylwin, S. J. B., Patterson, M., Borg, C. M., Wynne, K. J., Kent, A., Vincent, R. P., Gardiner, J., Ghatei, M. A., et al. (2006) · Endocrinology · doi:10.1210/en.2005-0972 · Cited by 552
Laferrère, B., Heshka, S., Wang, K., Khan, Y., McGinty, J., Teixeira, J., Hart, A. B., & Olivan, B. (2007) · Diabetes Care · doi:10.2337/dc06-1549 · Cited by 532
Peterli, R., Steinert, R. E., Woelnerhanssen, B., Peters, T., Christoffel-Courtin, C., Gass, M., Kern, B., von Fluee, M., & Beglinger, C. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0622-3 · Cited by 529
Cummings, D. E., Frayo, R. S., Marmonier, C., Aubert, R., & Chapelot, D. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00582.2003 · Cited by 527
Treatment of Obesity by Moderate and Severe Caloric Restriction: Results of Clinical Research Trials
Wadden, T. A. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-7_part_2-199310011-00012 · Cited by 470
Biology's response to dieting: the impetus for weight regain
MacLean, P. S., Bergouignan, A., Cornier, M.-A., & Jackman, M. R. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00755.2010 · Cited by 446
Laparoscopic Sleeve Gastrectomy—Volume and Pressure Assessment
Yehoshua, R. T., Eidelman, L. A., Stein, M., Fichman, S., Mazor, A., Chen, J., Bernstine, H., Singer, P., Dickman, R., Shikora, S. A., et al. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9576-x · Cited by 440
Subcutaneous Oxyntomodulin Reduces Body Weight in Overweight and Obese Subjects
Wynne, K., Park, A. J., Small, C. J., Patterson, M., Ellis, S. M., Murphy, K. G., Wren, A. M., Frost, G. S., Meeran, K., Ghatei, M. A., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.8.2390 · Cited by 435 · cited 1×
“Exogenous administration of OXM reduces food intake and increases energy expenditure in humans [117,118].”
BackgroundHøjberg, P. V., Vilsbøll, T., Rabøl, R., Knop, F. K., Bache, M., Krarup, T., Holst, J. J., & Madsbad, S. (2009) · Diabetologia · doi:10.1007/s00125-008-1195-5 · Cited by 414
Fildes, A., Charlton, J., Rudisill, C., Littlejohns, P., Prevost, A. T., & Gulliford, M. C. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302773 · Cited by 394
Sleeve Gastrectomy — A Restrictive Procedure?
Melissas, J., Koukouraki, S., Askoxylakis, J., Stathaki, M., Daskalakis, M., Perisinakis, K., & Karkavitsas, N. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9006-5 · Cited by 385
Goldfine, A. B., Mun, E. C., Devine, E., Bernier, R., Baz-Hecht, M., Jones, D. B., Schneider, B. E., Holst, J. J., & Patti, M. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0918 · Cited by 377
Wynne, K., Park, A. J., Small, C. J., Meeran, K., Ghatei, M. A., Frost, G. S., & Bloom, S. R. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803344 · Cited by 363 · cited 1×
“Exogenous administration of OXM reduces food intake and increases energy expenditure in humans [117,118].”
BackgroundMechanisms underlying weight loss after bariatric surgery
Miras, A. D., & le Roux, C. W. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.119 · Cited by 344
Jacobsen, S. H., Olesen, S. C., Dirksen, C., Jørgensen, N. B., Bojsen-Møller, K. N., Kielgast, U., Worm, D., Almdal, T., Naver, L. S., Hvolris, L. E., et al. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0621-4 · Cited by 342
Korner, J., Inabnet, W., Febres, G., Conwell, I. M., McMahon, D. J., Salas, R., Taveras, C., Schrope, B., & Bessler, M. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.79 · Cited by 338
The role of peptide YY in appetite regulation and obesity
Karra, E., Chandarana, K., & Batterham, R. L. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.164269 · Cited by 336
Tong, J., Prigeon, R. L., Davis, H. W., Bidlingmaier, M., Kahn, S. E., Cummings, D. E., Tschöp, M. H., & D'Alessio, D. (2010) · Diabetes · doi:10.2337/db10-0504 · Cited by 333
Salehi, M., Prigeon, R. L., & D’Alessio, D. A. (2011) · Diabetes · doi:10.2337/db11-0203 · Cited by 323 · cited 2×
“Salehi 2011 [175] RYGB without symptoms of PHH 12 (75%) MMTT with clamp MMTT, 57% carbs, 15% protein, 28% fat 7500 pmol/kg bolus and then 750 pmol/kg/min OR saline (IV) 47 ± 2 52 ± 2 33 ± 1 3.”
BackgroundFalkén, Y., Hellström, P. M., Holst, J. J., & Näslund, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2876 · Cited by 315
Jørgensen, N. B., Jacobsen, S. H., Dirksen, C., Bojsen-Møller, K. N., Naver, L., Hvolris, L., Clausen, T. R., Wulff, B. S., Worm, D., Lindqvist Hansen, D., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00073.2012 · Cited by 313 · cited 1×
“However, after bariatric surgery, the improvement in glucose homeostasis for people with T2D is observed from the first postoperative days, supporting the existence of weight loss independent mechanisms [36,133].”
BackgroundWeight Regain in U.S. Adults Who Experienced Substantial Weight Loss, 1999–2002
Weiss, E. C., Galuska, D. A., Kettel Khan, L., Gillespie, C., & Serdula, M. K. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.02.040 · Cited by 307 · cited 1×
“These findings are different to what is observed after low-calorie diet, which can be very effective in the induction of weight loss, however, the vast majority of people fail to maintain the achieved weight loss in the long-term [6,7,25,26].”
BackgroundNannipieri, M., Baldi, S., Mari, A., Colligiani, D., Guarino, D., Camastra, S., Barsotti, E., Berta, R., Moriconi, D., Bellini, R., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2538 · Cited by 293
Blockade of Glucagon-like Peptide 1 Receptor Corrects Postprandial Hypoglycemia After Gastric Bypass
Salehi, M., Gastaldelli, A., & D'Alessio, D. A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.044 · Cited by 289 · cited 4×
“Salehi 2014 [144] RYGB with established PHH 9 (100%) MMTT, 350 kcal, 57% carbs, 28% fat, 15% protein 7500 pmol/kg bolus and then 750 pmol/kg/min OR saline (IV) 44.”
BackgroundMethodInfluentialJørgensen, N. B., Dirksen, C., Bojsen-Møller, K. N., Jacobsen, S. H., Worm, D., Hansen, D. L., Kristiansen, V. B., Naver, L., Madsbad, S., & Holst, J. J. (2013) · Diabetes · doi:10.2337/db13-0022 · Cited by 288
Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5
Kushner, R. F., Calanna, S., Davies, M., Dicker, D., Garvey, W. T., Goldman, B., Lingvay, I., Thomsen, M., Wadden, T. A., Wharton, S., et al. (2020) · Obesity · doi:10.1002/oby.22794 · Cited by 288 · cited 1×
“8% [8] and help with weight maintenance [7,9], but newer medications promise more weight loss in the long term [10,11].”
BackgroundSleeve Gastrectomy—A “Food Limiting” Operation
Melissas, J., Daskalakis, M., Koukouraki, S., Askoxylakis, I., Metaxari, M., Dimitriadis, E., Stathaki, M., & Papadakis, J. A. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9634-4 · Cited by 277
Dirksen, C., Jørgensen, N. B., Bojsen-Møller, K. N., Kielgast, U., Jacobsen, S. H., Clausen, T. R., Worm, D., Hartmann, B., Rehfeld, J. F., Damgaard, M., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.15 · Cited by 276
Kashyap, S. R., Daud, S., Kelly, K. R., Gastaldelli, A., Win, H., Brethauer, S., Kirwan, J. P., & Schauer, P. R. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.254 · Cited by 274
Marsk, R., Jonas, E., Rasmussen, F., & Näslund, E. (2010) · Diabetologia · doi:10.1007/s00125-010-1798-5 · Cited by 273
The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones
Meek, C. L., Lewis, H. B., Reimann, F., Gribble, F. M., & Park, A. J. (2016) · Peptides · doi:10.1016/j.peptides.2015.08.013 · Cited by 269
Jackness, C., Karmally, W., Febres, G., Conwell, I. M., Ahmed, L., Bessler, M., McMahon, D. J., & Korner, J. (2013) · Diabetes · doi:10.2337/db12-1762 · Cited by 267
Yousseif, A., Emmanuel, J., Karra, E., Millet, Q., Elkalaawy, M., Jenkinson, A. D., Hashemi, M., Adamo, M., Finer, N., Fiennes, A. G., et al. (2014) · Obesity Surgery · doi:10.1007/s11695-013-1066-0 · Cited by 259
Bojsen-Møller, K. N., Dirksen, C., Jørgensen, N. B., Jacobsen, S. H., Serup, A. K., Albers, P. H., Hansen, D. L., Worm, D., Naver, L., Kristiansen, V. B., et al. (2014) · Diabetes · doi:10.2337/db13-1307 · Cited by 254
Effects of diet versus gastric bypass on metabolic function in diabetes
Yoshino, M., Kayser, B. D., Yoshino, J., Stein, R. I., Reeds, D., Eagon, J. C., Eckhouse, S. R., Watrous, J. D., Jain, M., Knight, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2003697 · Cited by 246 · cited 3×
“assessed the changes in glucose homeostasis before and after matched weight loss induced by RYGB (n = 22) or diet alone (n = 22) in people with obesity and T2D [132].”
BackgroundMethodJohansson, K., Neovius, M., & Hemmingsson, E. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.070052 · Cited by 243 · cited 2×
“8% [8] and help with weight maintenance [7,9], but newer medications promise more weight loss in the long term [10,11].”
BackgroundDeane, A. M., Nguyen, N. Q., Stevens, J. E., Fraser, R. J. L., Holloway, R. H., Besanko, L. K., Burgstad, C., Jones, K. L., Chapman, M. J., Rayner, C. K., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1503 · Cited by 238
The Role of GLP-1 in the Metabolic Success of Bariatric Surgery
Hutch, C. R., & Sandoval, D. (2017) · Endocrinology · doi:10.1210/en.2017-00564 · Cited by 236
Kuhre, R. E., Wewer Albrechtsen, N. J., Larsen, O., Jepsen, S. L., Balk-Møller, E., Andersen, D. B., Deacon, C. F., Schoonjans, K., Reimann, F., Gribble, F. M., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.03.007 · Cited by 229
Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release
Rodieux, F., Giusti, V., D'Alessio, D. A., Suter, M., & Tappy, L. (2008) · Obesity · doi:10.1038/oby.2007.83 · Cited by 216
Effect of liver fat on insulin clearance
Kotronen, A., Vehkavaara, S., Seppälä-Lindroos, A., Bergholm, R., & Yki-Järvinen, H. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00444.2007 · Cited by 202 · cited 1×
“During the first postoperative weeks, the improvement in hepatic insulin sensitivity and insulin clearance due to calorie restriction and reduction in liver fat are contributed to the improvement in glucose homeostasis [36,39,134].”
BackgroundMechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss
Holst, J. J., Madsbad, S., Bojsen-Møller, K. N., Svane, M. S., Jørgensen, N. B., Dirksen, C., & Martinussen, C. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.03.003 · Cited by 202
The effect of rate of weight loss on long-term weight management: a randomised controlled trial
Purcell, K., Sumithran, P., Prendergast, L. A., Bouniu, C. J., Delbridge, E., & Proietto, J. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70200-1 · Cited by 201
Mentis, N., Vardarli, I., Köthe, L. D., Holst, J. J., Deacon, C. F., Theodorakis, M., Meier, J. J., & Nauck, M. A. (2011) · Diabetes · doi:10.2337/db10-1332 · Cited by 197 · cited 1×
“On the other hand, in people with T2D, the insulinotropic capacity of exogenous GIP is markedly attenuated, but it appears to be improved after near-normalisation of glycaemic control [41,95,96].”
BackgroundChanges of Body Weight and Plasma Ghrelin Levels after Gastric Banding and Gastric Bypass
Stoeckli, R., Chanda, R., Langer, I., & Keller, U. (2004) · Obesity Research · doi:10.1038/oby.2004.43 · Cited by 194
Miras, A. D., Pérez-Pevida, B., Aldhwayan, M., Kamocka, A., McGlone, E. R., Al-Najim, W., Chahal, H., Batterham, R. L., McGowan, B., Khan, O., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30157-3 · Cited by 190
Glucagon and Amino Acids Are Linked in a Mutual Feedback Cycle: The Liver–α-Cell Axis
Holst, J. J., Wewer Albrechtsen, N. J., Pedersen, J., & Knop, F. K. (2017) · Diabetes · doi:10.2337/db16-0994 · Cited by 187
Steinert, R. E., Peterli, R., Keller, S., Meyer‐Gerspach, A. C., Drewe, J., Peters, T., & Beglinger, C. (2013) · Obesity · doi:10.1002/oby.20522 · Cited by 186
Wewer Albrechtsen, N. J., Hartmann, B., Veedfald, S., Windeløv, J. A., Plamboeck, A., Bojsen-Møller, K. N., Idorn, T., Feldt-Rasmussen, B., Knop, F. K., Vilsbøll, T., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3283-z · Cited by 185
Svane, M. S., Jørgensen, N. B., Bojsen-Møller, K. N., Dirksen, C., Nielsen, S., Kristiansen, V. B., Toräng, S., Wewer Albrechtsen, N. J., Rehfeld, J. F., Hartmann, B., et al. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.121 · Cited by 185 · cited 5×
“The increase in PYY levels was interpreted to indicate that while an inhibitory effect of GLP-1 on food intake may have been removed with the antagonist, at the same time an even greater PYY response occurs, which would favour inhibition of food intake so that the influence of Ex-9 on food intake after RYGB is neutral…”
BackgroundMethodInfluentialDirksen, C., Damgaard, M., Bojsen‐Møller, K. N., Jørgensen, N. B., Kielgast, U., Jacobsen, S. H., Naver, L. S., Worm, D., Holst, J. J., Madsbad, S., et al. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12087 · Cited by 184
Molecular Mechanisms of Glucose-Stimulated GLP-1 Secretion From Perfused Rat Small Intestine
Kuhre, R. E., Frost, C. R., Svendsen, B., & Holst, J. J. (2015) · Diabetes · doi:10.2337/db14-0807 · Cited by 180
Nannipieri, M., Mari, A., Anselmino, M., Baldi, S., Barsotti, E., Guarino, D., Camastra, S., Bellini, R., Berta, R. D., & Ferrannini, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0446 · Cited by 178
Food Intake and Eating Behavior After Bariatric Surgery
Al-Najim, W., Docherty, N. G., & le Roux, C. W. (2018) · Physiological Reviews · doi:10.1152/physrev.00021.2017 · Cited by 173
Andersen, J. R., Aasprang, A., Karlsen, T.-I., Karin Natvig, G., Våge, V., & Kolotkin, R. L. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.10.027 · Cited by 167
Potential Hormone Mechanisms of Bariatric Surgery
Dimitriadis, G. K., Randeva, M. S., & Miras, A. D. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0276-5 · Cited by 167
Mion, F., Tolone, S., Garros, A., Savarino, E., Pelascini, E., Robert, M., Poncet, G., Valette, P.-J., Marjoux, S., Docimo, L., et al. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2127-y · Cited by 160
Lee, C. J., Clark, J. M., Schweitzer, M., Magnuson, T., Steele, K., Koerner, O., & Brown, T. T. (2015) · Obesity · doi:10.1002/oby.21042 · Cited by 159 · cited 1×
“PHH is a condition which often affects people without T2D preoperatively and is likely to be the outcome of the altered nutrient delivery and altered glucose absorption after RYGB rather than inherent beta-cell hypertrophy or hyperfunction [64,164].”
BackgroundAlterations of Global Gastrointestinal Motility After Sleeve Gastrectomy: A Prospective Study
Melissas, J., Leventi, A., Klinaki, I., Perisinakis, K., Koukouraki, S., de Bree, E., & Karkavitsas, N. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182774522 · Cited by 155
Svane, M. S., Bojsen-Møller, K. N., Martinussen, C., Dirksen, C., Madsen, J. L., Reitelseder, S., Holm, L., Rehfeld, J. F., Kristiansen, V. B., van Hall, G., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.262 · Cited by 151
Wharton, S., Kuk, J. L., Luszczynski, M., Kamran, E., & Christensen, R. A. G. (2019) · Clinical Obesity · doi:10.1111/cob.12323 · Cited by 144 · cited 1×
“0 mg after bariatric surgery have reported similar results regarding weight loss [179].”
ResultMcCarty, T. R., Jirapinyo, P., & Thompson, C. C. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003614 · Cited by 139
Shah, M., Law, J. H., Micheletto, F., Sathananthan, M., Dalla Man, C., Cobelli, C., Rizza, R. A., Camilleri, M., Zinsmeister, A. R., & Vella, A. (2014) · Diabetes · doi:10.2337/db13-0954 · Cited by 138
Rhee, N. A., Wahlgren, C. D., Pedersen, J., Mortensen, B., Langholz, E., Wandall, E., Friis, S., Vilmann, P., Paulsen, S. J., Kristiansen, V. B., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3696-3 · Cited by 137
Laferrère, B., Swerdlow, N., Bawa, B., Arias, S., Bose, M., Oliván, B., Teixeira, J., McGinty, J., & Rother, K. I. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2767 · Cited by 132
Unraveling oxyntomodulin, GLP1's enigmatic brother
Pocai, A. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0368 · Cited by 130
Plasma Ghrelin Modulation in Gastric Band Operation and Sleeve Gastrectomy
Wang, Y., & Liu, J. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9688-3 · Cited by 124
Jiménez, A., Casamitjana, R., Viaplana-Masclans, J., Lacy, A., & Vidal, J. (2013) · Diabetes Care · doi:10.2337/dc12-1535 · Cited by 123
Incidence of Hypoglycemia After Gastric Bypass vs Sleeve Gastrectomy: A Randomized Trial
Capristo, E., Panunzi, S., De Gaetano, A., Spuntarelli, V., Bellantone, R., Giustacchini, P., Birkenfeld, A. L., Amiel, S., Bornstein, S. R., Raffaelli, M., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01695 · Cited by 122
Evaluation of the incretin effect in humans using GIP and GLP-1 receptor antagonists
Gasbjerg, L. S., Bergmann, N. C., Stensen, S., Christensen, M. B., Rosenkilde, M. M., Holst, J. J., Nauck, M., & Knop, F. K. (2020) · Peptides · doi:10.1016/j.peptides.2019.170183 · Cited by 121 · cited 3×
“Finally, the increased levels of PYY and GLP-1 after Ex-9 administration [130] may suggest that Ex-9 interfere with intestinal endocrine feedback loops [155] which may also affect the glucose levels.”
BackgroundCritical role for GLP-1 in symptomatic post-bariatric hypoglycaemia
Craig, C. M., Liu, L.-F., Deacon, C. F., Holst, J. J., & McLaughlin, T. L. (2017) · Diabetologia · doi:10.1007/s00125-016-4179-x · Cited by 120
Nguyen, N. Q., Debreceni, T. L., Bambrick, J. E., Bellon, M., Wishart, J., Standfield, S., Rayner, C. K., & Horowitz, M. (2014) · Obesity · doi:10.1002/oby.20791 · Cited by 119
Early Changes in Ghrelin following Roux-en-Y Gastric Bypass: Influence of Vagal Nerve Functionality?
Sundbom, M., Holdstock, C., Engström, B. E., & Karlsson, F. A. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9056-8 · Cited by 119
Jacobsen, S. H., Bojsen-Møller, K. N., Dirksen, C., Jørgensen, N. B., Clausen, T. R., Wulff, B. S., Kristiansen, V. B., Worm, D., Hansen, D. L., Holst, J. J., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3003-0 · Cited by 115
Papamargaritis, D., Koukoulis, G., Sioka, E., Zachari, E., Bargiota, A., Zacharoulis, D., & Tzovaras, G. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0711-3 · Cited by 112
Self-citationPatterns of Weight Loss Response Following Gastric Bypass and Sleeve Gastrectomy
de Hollanda, A., Ruiz, T., Jiménez, A., Flores, L., Lacy, A. M., & Vidal, J. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1512-7 · Cited by 109
Dirksen, C., Hansen, D. L., Madsbad, S., Hvolris, L. E., Naver, L. S., Holst, J. J., & Worm, D. (2010) · Diabetes Care · doi:10.2337/dc09-1374 · Cited by 107
The Effects of Bariatric Surgery on Islet Function, Insulin Secretion, and Glucose Control
Douros, J. D., Tong, J., & D’Alessio, D. A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00183 · Cited by 106
Bose, M., Machineni, S., Oliván, B., Teixeira, J., McGinty, J. J., Bawa, B., Koshy, N., Colarusso, A., & Laferrère, B. (2010) · Obesity · doi:10.1038/oby.2009.473 · Cited by 102
Mans, E., Serra‐Prat, M., Palomera, E., Suñol, X., & Clavé, P. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.104307 · Cited by 100
Measurement of gastric emptying after gastric bypass surgery using radionuclides
Horowitz, M., Cook, D. J., Collins, P. J., Harding, P. E., Hooper, M. J., Walsh, J. F., & Shearman, D. J. C. (1982) · Journal of British Surgery · doi:10.1002/bjs.1800691108 · Cited by 99
PYY and NPY: control of gastric motility via action on Y1 and Y2 receptors in the DVC
Chen, C. ‐., Stephens Jr, R. L., & Rogers, R. C. (1997) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.1997.d01-26.x · Cited by 98
Medical Nutrition Therapy for Post-Bariatric Hypoglycemia: Practical Insights
Suhl, E., Anderson-Haynes, S.-E., Mulla, C., & Patti, M.-E. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.01.025 · Cited by 96 · cited 1×
“Patients are commonly advised to follow dietary modifications of small and frequent meals with controlled portions of low glycaemic index carbohydrates [170].”
BackgroundGLP-1 and Glucose Tolerance After Sleeve Gastrectomy in Morbidly Obese Subjects With Type 2 Diabetes
Jiménez, A., Mari, A., Casamitjana, R., Lacy, A., Ferrannini, E., & Vidal, J. (2014) · Diabetes · doi:10.2337/db14-0357 · Cited by 95
Makaronidis, J. M., Neilson, S., Cheung, W.-H., Tymoszuk, U., Pucci, A., Finer, N., Doyle, J., Hashemi, M., Elkalaawy, M., Adamo, M., et al. (2016) · Appetite · doi:10.1016/j.appet.2016.07.029 · Cited by 94 · cited 1×
“The changes in satiety are profound from the early postoperative period after RYGB and SG and, in some cases, there are also alterations in food preferences after these procedures [23,24].”
BackgroundPerakakis, N., Kokkinos, A., Peradze, N., Tentolouris, N., Ghaly, W., Pilitsi, E., Upadhyay, J., Alexandrou, A., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2019.153997 · Cited by 93
Valderas, J. P., Irribarra, V., Boza, C., de la Cruz, R., Liberona, Y., Acosta, A. M., Yolito, M., & Maiz, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0983 · Cited by 92
Shak, J. R., Roper, J., Perez-Perez, G. I., Tseng, C., François, F., Gamagaris, Z., Patterson, C., Weinshel, E. H., Fielding, G., Ren, C. J., et al. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9454-6 · Cited by 91
Dutia, R., Embrey, M., O'Brien, S., Haeusler, R. A., Agénor, K. K., Homel, P., McGinty, J., Vincent, R. P., Alaghband-Zadeh, J., Staels, B., et al. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.1 · Cited by 91
Emous, M., Wolffenbuttel, B. H. R., Totté, E., & van Beek, A. P. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.04.028 · Cited by 89
Nemati, R., Lu, J., Dokpuang, D., Booth, M., Plank, L. D., & Murphy, R. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3216-x · Cited by 88
Suliman, M., Buckley, A., Al Tikriti, A., Tan, T., le Roux, C. W., Lessan, N., & Barakat, M. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13672 · Cited by 86 · cited 1×
“0 mg (licensed for treatment of obesity) was evaluated in patients who have had bariatric surgery (n = 188), as well as non-surgical patients [178].”
BackgroundBelgaumkar, A. P., Vincent, R. P., Carswell, K. A., Hughes, R. D., Alaghband-Zadeh, J., Mitry, R. R., le Roux, C. W., & Patel, A. G. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1878-1 · Cited by 83
Arakawa, R., Febres, G., Cheng, B., Krikhely, A., Bessler, M., & Körner, J. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236133 · Cited by 79
Martinussen, C., Bojsen-Møller, K. N., Dirksen, C., Jacobsen, S. H., Jørgensen, N. B., Kristiansen, V. B., Holst, J. J., & Madsbad, S. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00506.2014 · Cited by 74
Mechanisms Underlying Type 2 Diabetes Remission After Metabolic Surgery
Pérez‐Pevida, B., Escalada, J., Miras, A. D., & Frühbeck, G. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00641 · Cited by 73
Changes in gut hormone profile and glucose homeostasis after laparoscopic sleeve gastrectomy
Papamargaritis, D., le Roux, C. W., Sioka, E., KOUKOULIS, G. N., Tzovaras, G. A., & Zacharoulis, D. (2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.08.007 · Cited by 72
Self-citationAccelerated protein digestion and amino acid absorption after Roux-en-Y gastric bypass
Bojsen-Møller, K. N., Jacobsen, S. H., Dirksen, C., Jørgensen, N. B., Reitelseder, S., Jensen, J. B., Kristiansen, V. B., Holst, J. J., van Hall, G., & Madsbad, S. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.109298 · Cited by 72
Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery
Svane, M. S., Bojsen-Møller, K. N., Nielsen, S., Jørgensen, N. B., Dirksen, C., Bendtsen, F., Kristiansen, V. B., Hartmann, B., Holst, J. J., & Madsbad, S. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00471.2015 · Cited by 72
Vetter, M. L., Wadden, T. A., Teff, K. L., Khan, Z. F., Carvajal, R., Ritter, S., Moore, R. H., Chittams, J. L., Iagnocco, A., Murayama, K., et al. (2015) · Diabetes · doi:10.2337/db14-0558 · Cited by 71
Steven, S., Hollingsworth, K. G., Small, P. K., Woodcock, S. A., Pucci, A., Aribasala, B., Al‐Mrabeh, A., Batterham, R. L., & Taylor, R. (2016) · Diabetic Medicine · doi:10.1111/dme.13257 · Cited by 71 · cited 2×
“During the first postoperative weeks, the improvement in hepatic insulin sensitivity and insulin clearance due to calorie restriction and reduction in liver fat are contributed to the improvement in glucose homeostasis [36,39,134].”
BackgroundNielsen, M. S., Ritz, C., Wewer Albrechtsen, N. J., Holst, J. J., le Roux, C. W., & Sjödin, A. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa061 · Cited by 65 · cited 9×
“Limited data is also available on the changes of glicentin levels after bariatric surgery [23,33,97], however postprandial glicentin levels appear to be elevated after RYGB (Table 1).”
BackgroundInfluentialMadsbad, S., & Holst, J. J. (2014) · Diabetes · doi:10.2337/db14-0935 · Cited by 64
Weight regain in patients with symptoms of post–bariatric surgery hypoglycemia
Varma, S., Clark, J. M., Schweitzer, M., Magnuson, T., Brown, T. T., & Lee, C. J. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.06.004 · Cited by 64
Hypoglycemia in everyday life after gastric bypass and duodenal switch
Abrahamsson, N., Edén Engström, B., Sundbom, M., & Karlsson, F. A. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0821 · Cited by 63
Systematic Review and Meta-analysis of the Change in Ghrelin Levels After Roux-en-Y Gastric Bypass
Xu, H.-C., Pang, Y.-C., Chen, J.-W., Cao, J.-Y., Sheng, Z., Yuan, J.-H., Wang, R., Zhang, C.-S., Wang, L.-X., & Dong, J. (2019) · Obesity Surgery · doi:10.1007/s11695-018-03686-3 · Cited by 63
Tharakan, G., Behary, P., Wewer Albrechtsen, N. J., Chahal, H., Kenkre, J., Miras, A. D., Ahmed, A. R., Holst, J. J., Bloom, S. R., & Tan, T. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0446 · Cited by 61
Davis, D. B., Khoraki, J., Ziemelis, M., Sirinvaravong, S., Han, J. Y., & Campos, G. M. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2017.12.011 · Cited by 60
Diagnostic tools for post‐gastric bypass hypoglycaemia
Emous, M., Ubels, F. L., & van Beek, A. P. (2015) · Obesity Reviews · doi:10.1111/obr.12307 · Cited by 58
Miras, A. D., Kamocka, A., Patel, D. R., Dexter, S. P. L., Finlay, I. G., Hopkins, J. C. A., Khan, O. A., Reddy, M., Sedman, P. C., Small, P. K., et al. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.02.012 · Cited by 58
Effect of calorie restriction on subjective ratings of appetite
Anton, S. D., Han, H., York, E., Martin, C. K., Ravussin, E., & Williamson, D. A. (2009) · Journal of Human Nutrition and Dietetics · doi:10.1111/j.1365-277x.2008.00943.x · Cited by 56
Bonouvrie, D. S., Uittenbogaart, M., Luijten, A. A. P. M., van Dielen, F. M. H., & Leclercq, W. K. G. (2019) · Obesity Surgery · doi:10.1007/s11695-018-3610-4 · Cited by 56 · cited 1×
“There is a lack of standardisation in definitions for primary and secondary “poor” responders and “good” responders [126,127].”
BackgroundEffect of bypassing the proximal gut on gut hormones involved with glycemic control and weight loss
Pournaras, D. J., Aasheim, E. T., Bueter, M., Ahmed, A. R., Welbourn, R., Olbers, T., & le Roux, C. W. (2012) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2012.01.021 · Cited by 55
Wallenius, V., Dirinck, E., Fändriks, L., Maleckas, A., le Roux, C. W., & Thorell, A. (2018) · Obesity Surgery · doi:10.1007/s11695-017-3061-3 · Cited by 55
Gu, L., Fu, R., Chen, P., Du, N., Chen, S., Mao, D., Chen, B., Mao, F., Khadaroo, P. A., & Jin, Q. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04488-2 · Cited by 55
Incidence and Predictors of Hypoglycemia 1 Year After Laparoscopic Sleeve Gastrectomy
Belligoli, A., Sanna, M., Serra, R., Fabris, R., Prà, C. D., Conci, S., Fioretto, P., Prevedello, L., Foletto, M., Vettor, R., et al. (2017) · Obesity Surgery · doi:10.1007/s11695-017-2742-2 · Cited by 53
Gastrointestinal hormones and weight loss response after Roux-en-Y gastric bypass
de Hollanda, A., Jiménez, A., Corcelles, R., Lacy, A. M., Patrascioiu, I., & Vidal, J. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.01.022 · Cited by 52
Nauck, M. A., Kind, J., Köthe, L. D., Holst, J. J., Deacon, C. F., Broschag, M., He, Y. L., Kjems, L., & Foley, J. (2016) · Diabetes · doi:10.2337/db16-0107 · Cited by 52
Gastrectomy with Roux-en-Y reconstruction as a lean model of bariatric surgery
Roberts, G. P., Kay, R. G., Howard, J., Hardwick, R. H., Reimann, F., & Gribble, F. M. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.01.039 · Cited by 51
Tsouristakis, A. I., Febres, G., McMahon, D. J., Tchang, B. G., Conwell, I. M., Tsang, A., Ahmed, L., Bessler, M., & Körner, J. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04111-z · Cited by 49
Craig, C. M., Liu, L., Nguyen, T., Price, C., Bingham, J., & McLaughlin, T. L. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13078 · Cited by 48
Weight Loss After Laparoscopic Adjustable Gastric Banding is not Caused by Altered Gastric Emptying
de Jong, J. R., van Ramshorst, B., Gooszen, H. G., Smout, A. J. P. M., & Buul, M. M. C. T.-V. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9746-x · Cited by 47
Tong, J., Davis, H. W., Gastaldelli, A., & D’Alessio, D. A. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4154 · Cited by 46
Stano, S., Alam, F., Wu, L., Dutia, R., Ng, S.-N., Sala, M., McGinty, J., & Laferrère, B. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.09.004 · Cited by 46
Ybarra, J., Bobbioni-Harsch, E., Chassot, G., Huber, O., Morel, P., Assimacopoulos‐Jeannet, F., & Golay, A. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9748-8 · Cited by 44
Postprandial hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: an update
Øhrstrøm, C. C., Worm, D., & Hansen, D. L. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.09.025 · Cited by 42
Lupoli, R., Lembo, E., Ciciola, P., Schiavo, L., Pilone, V., & Capaldo, B. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.06.029 · Cited by 41
Barazzoni, R., Zanetti, M., Nagliati, C., Cattin, M. R., Ferreira, C., Giuricin, M., Palmisano, S., Edalucci, E., Dore, F., Guarnieri, G., et al. (2013) · Obesity · doi:10.1002/oby.20272 · Cited by 40
Nielsen, S., Svane, M. S., Kuhre, R. E., Clausen, T. R., Kristiansen, V. B., Rehfeld, J. F., Holst, J. J., Madsbad, S., & Bojsen‐Moller, K. N. (2017) · Physiological Reports · doi:10.14814/phy2.13140 · Cited by 40
Kuhre, R. E., Christiansen, C. B., Saltiel, M. Y., Wewer Albrechtsen, N. J., & Holst, J. J. (2017) · Physiological Reports · doi:10.14814/phy2.13507 · Cited by 40
Acute Changes of Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass
Chen, Y., Lu, J., Nemati, R., Plank, L. D., & Murphy, R. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04040-x · Cited by 39
Investigating Intestinal Glucagon After Roux-en-Y Gastric Bypass Surgery
Jorsal, T., Albrechtsen, N. J. W., Christensen, M. M., Mortensen, B., Wandall, E., Langholz, E., Friis, S., Worm, D., Ørskov, C., Støving, R. K., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00062 · Cited by 39
Usinger, L., Hansen, K. B., Kristiansen, V. B., Larsen, S., Holst, J. J., & Knop, F. K. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0362-9 · Cited by 38
Gu, L., Lin, K., Du, N., Ng, D. M., Lou, D., & Chen, P. (2021) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.10.018 · Cited by 37
Tan, M., Lamendola, C., Luong, R., McLaughlin, T., & Craig, C. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14048 · Cited by 36
Vaurs, C., Brun, J. ‐., Bertrand, M., Burcelin, R., du Rieu, M. C., Anduze, Y., Hanaire, H. P., & Ritz, P. (2015) · Metabolism · doi:10.1016/j.metabol.2015.10.020 · Cited by 34
Cracking the combination: Gut hormones for the treatment of obesity and diabetes
Alexiadou, K., Anyiam, O., & Tan, T. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12664 · Cited by 34
Martinussen, C., Veedfald, S., Dirksen, C., Bojsen-Møller, K. N., Svane, M. S., Albrechtsen, N. J. W., van Hall, G., Kristiansen, V. B., Fenger, M., Holst, J. J., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00023.2020 · Cited by 34
Miras, A. D., Al‐Najim, W., Jackson, S. N., McGirr, J., Cotter, L., Tharakan, G., Vusirikala, A., le Roux, C. W., Prechtl, C. G., & Scholtz, S. (2014) · Scandinavian Journal of Surgery · doi:10.1177/1457496914543977 · Cited by 32
Prevalence of hypoglycaemia in a random population after Roux-en-Y gastric bypass after a meal test
Emous, M., van den Broek, M., Wijma, R. B., de Heide, L. J. M., van Dijk, G., Laskewitz, A. J., Totté, E., Wolffenbuttel, B. H. R., & van Beek, A. P. (2019) · Endocrine Connections · doi:10.1530/ec-19-0268 · Cited by 31
Neff, K., Chuah, L. L., Aasheim, E. T., Jackson, S., Dubb, S. S., Radhakrishnan, S. T., Sood, A. S., Olbers, T., Godsland, I. F., Miras, A. D., et al. (2013) · Obesity Surgery · doi:10.1007/s11695-013-1164-z · Cited by 30
Αλεξιάδου, Κ., Cuenco, J., Howard, J., Albrechtsen, N. J. W., Ilesanmi, I., Kamocka, A., Tharakan, G., Behary, P., Bech, P., Ahmed, A., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001076 · Cited by 30
Gribble, F. M., Reimann, F., & Roberts, G. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00002-5 · Cited by 30
The Role of Gut Hormones in Diet-Induced Weight Change: A Systematic Review
Zhao, X., Han, Q., Gang, X., Lv, Y., Liu, Y., Sun, C., & Wang, G. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-115646 · Cited by 29
Shah, A. M., Holter, M. M., Rimawi, F., Mark, V., Dutia, R., McGinty, J., Levin, B. L., & Laferrère, B. (2018) · Diabetes Care · doi:10.2337/dc18-1036 · Cited by 29
Kokkinos, A. D., Tsilingiris, D., le Roux, C. W., Rubino, F., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2019.153960 · Cited by 29
GLP-1 is not the key mediator of the health benefits of metabolic surgery
Vidal, J., de Hollanda, A., & Jiménez, A. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.02.029 · Cited by 28
Eiken, A., Fuglsang, S., Eiken, M., Svane, M. S., Kuhre, R. E., Albrechtsen, N. J. W., Hansen, S. H., Trammell, S. A. J., Svenningsen, J. S., Rehfeld, J. F., et al. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0578-7 · Cited by 27
Gastrointestinal Hormones and Weight Loss Maintenance Following Roux-en-Y Gastric Bypass
de Hollanda, A., Casals, G., Delgado, S., Jiménez, A., Viaplana, J., Lacy, A. M., & Vidal, J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3065 · Cited by 26
Papamargaritis, D., Panteliou, E., Miras, A. D., & le Roux, C. W. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0283-7 · Cited by 25
Self-citationInfluence of diabetes surgery on gut hormones and incretins.
Papamargaritis, D., Miras, A. D., & le Roux, C. W. (2013) · PubMed · doi:10.3305/nh.2013.28.sup2.6719 · Cited by 24
Self-citationNguyen, N. Q., Debreceni, T. L., Burgess, J. E., Bellon, M., Wishart, J. M., Standfield, S., Malbert, C., & Horowitz, M. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0012-6 · Cited by 22
Octreotide in Dumping and Short Bowel Syndromes
Farthing, M. J. G. (2009) · Digestion · doi:10.1159/000201077 · Cited by 19
Bunt, J. C., Blackstone, R. P., Thearle, M. S., Vinales, K. L., Votruba, S. B., & Krakoff, J. A. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.22 · Cited by 19
Werling, M., Fändriks, L., Vincent, R. P., Cross, G. F., le Roux, C. W., & Olbers, T. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.04.018 · Cited by 12
Prior, S. L., Churm, R., Min, T., Dunseath, G. J., Barry, J. D., & Stephens, J. W. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04457-9 · Cited by 10
Garelli, F., Nericcio, A., Antonioli, L., et al. (2020) · Obesity Reviews · doi:10.1111/obr.13115 · Cited by 5
Chapter-05 Gastrointestinal Hormones
Muthayya, N. M. (2009) · NM Muthayya eBooks · doi:10.5005/jp/books/10366_20 · Cited by 2
The Duration of overweight and risk of chronic diseases: The Kaunas Cardiovascular Risk Cohort Study
Kriaučionienė, V., Raskilienė, A., & Petkevičienė, J. (2020) · doi:10.1111/obr.12149/pdf · Cited by 2
Cited by
What is the pipeline for future medications for obesity?
Melson, E., Ashraf, U., Papamargaritis, D., & Davies, M. J. (2025) · International Journal of Obesity · doi:10.1038/s41366-024-01473-y · Cited by 332
“The notion for combining entero-pancreatic hormone-based therapies for obesity treatment is supported by the ef fi cacy of bariatric surgery on WL, an intervention leading to increased postprandial levels of multiple entero-pancreatic hormones [31, 32].”
Self-citationMok, J., Adeleke, M. O., Brown, A., Magee, C. G., Firman, C., Makahamadze, C., Jassil, F. C., Marvasti, P., Carnemolla, A., Devalia, K., et al. (2023) · JAMA Surgery · doi:10.1001/jamasurg.2023.2930 · Cited by 178
Jensen, A. B., Renström, F., Aczél, S., Folie, P., Biraima-Steinemann, M., Beuschlein, F., & Bilz, S. (2023) · Obesity Surgery · doi:10.1007/s11695-023-06484-8 · Cited by 161
Mechanisms of Weight Loss After Obesity Surgery
Akalestou, E., Miras, A. D., Rutter, G. A., & le Roux, C. W. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab022 · Cited by 136
Haddad, A. J., Suter, M., Greve, J. W. M., Shikora, S. A., Prager, G., Dayyeh, B. K. A., Neto, M. G., Grothe, K. B., Herrera, M. F., Kow, L., et al. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07489-7 · Cited by 85
“Studies have demonstrated accelerated alcohol absorption, higher maximum alcohol concentration [57], and higher rates of alcohol use disorder [47, 48, 58–60] after MBS. Opioid consumption may increase as well for some patients [61].”
Metadata
- Authors
- Papamargaritis, D., & le Roux, C. W.
- Affiliations
- University of Leicester (GB)
- Diabetes Complications Research Centre, Conway Institute, University College of Dublin, Dublin 4, Ireland
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2021-02-26
- Volume
- 13
- Issue
- 3
- Pages
- 762
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC7996890
- OpenAlex
- W3134150619
- Cited by
- 68
- References
- 182
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 20 · 2023: 13 · 2022: 10 · 2021: 6
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Ulster University Research Portal (Ulster University) (acceptedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
- Funders
- Health Research Board
- National Institute for Health and Care Research (CL-2017-11-001)
- Academy of Medical Sciences (SGL020\1002)
- Irish Research Council
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- gastrointestinal hormones, bariatric surgery, Roux-en-Y gastric bypass, sleeve gastrectomy, obesity, weight loss, glucose homeostasis, type 2 diabetes remission, postprandial hypoglycemia, appetite regulation, satiety, hunger, octreotide, exendin-9-39, GLP-1 receptor
- MeSH terms
- Adult, Blood Glucose, Combined Modality Therapy, Eating, Female, Gastrectomy, Gastrointestinal Hormones, Humans, Hunger, Male, Middle Aged, Obesity, Morbid, Peptide Fragments, Postoperative Period, Satiation, Octreotide, Gastric Bypass, Biomarkers, Weight Loss, Treatment Outcome, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
